HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Red cell and platelet kinetics in chronic cytopenias following transplantation.

Abstract
Thirty seven patients with unexplained anemia and/or thrombocytopenia after bone marrow, kidney, liver or heart transplantation were referred to the Department of Nuclear Medicine for erythrocyte or platelet kinetic studies in order to determine the mechanism of the cytopenia: accelerated destruction, or production defect. We observed only one definite case of thrombocytopenia due to accelerated autologous platelet destruction, while the life span was normal in the other 16 cases. Anemia was due to accelerated hemolysis in 7 cases, while the red blood cell life-span was normal in 12 other cases. Kinetic studies can therefore be useful, by demonstrating the mechanism of cytopenia observed after transplantation, and by facilitating the choice of appropriate treatment.
AuthorsY Najean, J D Rain, C Billotey
JournalHematology and cell therapy (Hematol Cell Ther) Vol. 39 Issue 5 Pg. 233-6 (Oct 1997) ISSN: 1269-3286 [Print] France
PMID9395897 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Blood Platelets (pathology)
  • Bone Marrow Transplantation (pathology)
  • Cell Cycle
  • Child
  • Chronic Disease
  • Erythrocytes (pathology)
  • Female
  • Heart Transplantation (pathology)
  • Humans
  • Kidney Transplantation (pathology)
  • Liver Transplantation (pathology)
  • Male
  • Middle Aged
  • Organ Transplantation (pathology)
  • Thrombocytopenia (etiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: